TMC the metals (TMC) Is Down 13.8% After NOAA Starts EIS Review on USA‑B Seafloor Project
TMC the metals company Inc. TMC | 0.00 |
- In August 2026, TMC the metals company Inc. reported that its second-quarter net loss narrowed to US$60.12 million, with basic and diluted loss per share from continuing operations improving to US$0.14, while the National Oceanic and Atmospheric Administration issued a Notice of Intent to prepare an Environmental Impact Statement for TMC USA’s USA‑B exploration license application.
- This Environmental Impact Statement process covers about 122,000 km² of seafloor with an estimated 1.02 billion tonnes of polymetallic nodules containing critical metals, underscoring how regulatory progress is intertwined with the company’s access to large-scale resource potential.
- With NOAA now formally initiating the Environmental Impact Statement for TMC’s USA‑B application, we’ll examine how this regulatory milestone affects its investment narrative.
Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.
TMC the metals Investment Narrative Recap
To own TMC today, you have to believe deep sea nodules can move from permitting and studies into commercial production under the U.S. regime, with acceptable environmental conditions and enough funding to bridge ongoing losses. NOAA’s Notice of Intent to prepare an Environmental Impact Statement for the USA B exploration license is a clear regulatory step, but it does not change that the short term catalyst remains permit progress and the biggest risk remains delay, restriction or denial of commercial approvals.
Among recent announcements, the Q2 2026 results stand out because they show TMC continuing to operate with no revenue while recording a quarterly net loss of US$60.12 million. Even with a narrower loss than a year ago, the business is still dependent on external capital to fund the long permitting and development path. That financial dependence sits directly beside the USA B EIS milestone in shaping how investors think about timing and scale of any eventual commercial recovery.
Yet investors should also weigh how tighter than expected EIS outcomes, or a slower route to a NOAA Commercial Recovery Permit, could materially change the story you are buying into...
TMC the metals' narrative projects $450.3 million revenue and $93.8 million earnings by 2029. This requires revenue to grow from effectively zero today and an earnings increase of about $389 million from -$295.5 million today.
Uncover how TMC the metals' forecasts yield a $11.20 fair value, a 186% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were, before this news, assuming TMC could reach about US$1.1 billion in revenue and roughly US$160 million in earnings by 2029, which is far more upbeat than the baseline view. If you are weighing that kind of upside against fresh NOAA steps and the possibility of slower or more constrained commercial approvals, it highlights how reasonable people can look at the same business and reach very different conclusions about risk and reward.
Explore 6 other fair value estimates on TMC the metals - why the stock might be worth less than half the current price!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your TMC the metals research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
- Our free TMC the metals research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate TMC the metals' overall financial health at a glance.
Looking For Alternative Opportunities?
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
- Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.
- Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
- AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
